"Our revelation of the virus' masking strategy is important, as it could pave the way for new ways of treating viral infections," says Jeppe Vinther. "And it is likely that other types of viruses use the same trick." (Credit: Marina Zaharkina/Unsplash )

‘Mask’ lets hepatitis C virus evade immune system

Researchers have solved the mystery of how the hepatitis C virus evades the immune system and spreads through the body: it puts on a "mask."

Michael Skov Jensen-Copenhagen • futurity
July 6, 2023 5 minSource

A new way to examine the hepatitis C virus has helped clarify how it evades the human immune system and spreads through the body: it puts on a “mask.”

An estimated 50 million people worldwide are infected with chronic hepatitis C. The hepatitis C virus can cause inflammation and scarring of the liver, and in the worst case, liver cancer.

Hepatitis C was discovered in 1989 and is one of the most studied viruses on the planet. Yet for decades, how it manages to evade the human immune system and spread through the body has been a riddle.

Donning a mask allows the virus to remain hidden while making copies of itself to infect new cells. The mask cloaks the virus in the form of a molecule already in our cells. Disguised by the molecule, our immune systems confuse the virus with something harmless that needn’t be reacted to.

“How the hepatitis C virus manages to hide in our liver cells without being detected by the immune system has always been a bit of a mystery,” says co-lead researcher Jeppe Vinther, associate professor in the biology department at the University of Copenhagen.

“Our revelation of the virus’ masking strategy is important, as it could pave the way for new ways of treating viral infections. And it is likely that other types of viruses use the same trick.”

Hepatitis C mystery solved

The mask the hepatitis virus uses to hide in our cells is called FAD, a molecule composed of vitamin B2 and the energy carrying molecule ATP. FAD is vital for our cells to convert energy. The FAD molecule’s importance and familiarity to our cells makes it ideal camouflage for a malicious virus.

For several years, the research team had a good idea that FAD was helping the virus hide in infected cells, but they lacked a clear way to prove it. To solve the challenge, they turned to Arabidopsis , a well-known experimental plant among researchers.

“We were getting desperate to find a way to prove our hypothesis, which is when we purified an enzyme from the Arabidopsis plant that can split the FAD molecule in two,” says Anna Sherwood from the biology department, who together with Lizandro Rene Rivera Rangel are first authors of the study.

Using the enzyme, the researchers were able to split the FAD and prove that the hepatitis C virus used it as a mask.

Hiding from immune system

Like both the coronavirus and influenza virus, hepatitis C is an RNA virus. Its genetic material consists of RNA that must be copied once the virus enters its host organism. New RNA copies are used to take over new cells, and one end of the RNA’s genetic material is masked by the FAD.

It is very realistic that other RNA viruses use similar masking techniques to spread without being detected by cellular control systems, Vinther says. In fact, researchers have already found another virus that uses the same strategy. And there are likely more.

“All RNA viruses have the same need to hide from the immune system and there is a good chance that this is just the beginning. Now that we’re attuned to this trick, it opens up the possibility of developing new and perhaps improved methods of tracking and treating viral infections in the future,” Vinther says.

The study is published in Nature .

Independent Research Fund Denmark funded the work.

Source: University of Copenhagen

The post ‘Mask’ lets hepatitis C virus evade immune system appeared first on Futurity .


Share this article:

This article uses material from the Futurity article, and is licenced under a CC BY-SA 4.0 International License. Images, videos and audio are available under their respective licenses.

Related Articles: